Cookie Preference Center We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.

Open in Who Shared View Duplicates (465)

Mo2112 LONG-TERM OUTCOMES OF APIXABAN VERSUS ENOXAPARIN FOR PORTAL VEIN THROMBOSIS IN CIRRHOSIS: A MULTICENTER PROPENSITY-MATCHED STUDY

May 01, 2026 |

By Mohamed Nadeem, Archana Kharel, Islam Mohamed, Mohamad-Noor Abu-Hammour, Rashid Abdel-Razeq, Basil Jalamneh, PRABHAT KUMAR, Barish Eren, Shilpa Junna

| Gastrointestinal Endoscopy

Cookie Preference Center We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.

Open in Who Shared View Duplicates (441)

See all 1,887 licensed articles (1,892 Total)

For PR Teams

Overview

Use Cases

Capabilities

Industries

Introducing Curation Engine

Resources

Library

Commmunity

Customers

Company

PRABHAT KUMAR

Get in touch with PRABHAT

Actions

Articles

Sa1927 HYDROSTATIC GRADIENT-DRIVEN NASOBILIARY DRAINAGE AND SEQUENTIAL ERCP FOR SUCCESSFUL NON-OPERATIVE MANAGEMENT OF A HIGH-GRADE TRAUMATIC BILE LEAK AFTER GRADE LIVER INJURY

Tu1562 COMPARATIVE PREGNANCY SAFETY OF ADVANCED THERAPIES IN IBD: A REAL-WORLD COHORT STUDY USING TRINETX

Mo2112 LONG-TERM OUTCOMES OF APIXABAN VERSUS ENOXAPARIN FOR PORTAL VEIN THROMBOSIS IN CIRRHOSIS: A MULTICENTER PROPENSITY-MATCHED STUDY

Actions

Is this you?

Get in touch with PRABHAT